- Home
- MDGL vs DOCN Comparison
MDGL vs DOCN Comparison
Compare MDGL & DOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | DOCN |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 13.2B |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MDGL | DOCN |
|---|---|---|
| Price | $534.40 | $132.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $674.45 | $85.46 |
| AVG Volume (30 Days) | 184.9K | ★ 2.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 183.15 |
| EPS | N/A | ★ 0.45 |
| Revenue | $180,133,000.00 | ★ $901,427,000.00 |
| Revenue This Year | $58.39 | $23.80 |
| Revenue Next Year | $48.55 | $30.11 |
| P/E Ratio | ★ N/A | $273.00 |
| Revenue Growth | N/A | ★ 15.48 |
| 52 Week Low | $393.61 | $33.69 |
| 52 Week High | $615.00 | $187.50 |
Technical Indicators
Market Signals| Indicator | MDGL | DOCN |
|---|---|---|
| Relative Strength Index (RSI) | 51.49 | 57.19 |
| Support Level | $529.02 | $126.05 |
| Resistance Level | $546.29 | $140.15 |
| Average True Range (ATR) | 15.77 | 8.35 |
| MACD | -1.12 | 1.75 |
| Stochastic Oscillator | 55.49 | 85.75 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.